Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
AstraZeneca
QuintilesIMS
Fish and Richardson
Fuji
Dow
Julphar
Queensland Health
McKesson

Generated: June 22, 2018

DrugPatentWatch Database Preview

Remifentanil hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for remifentanil hydrochloride and what is the scope of remifentanil hydrochloride freedom to operate?

Remifentanil hydrochloride
is the generic ingredient in two branded drugs marketed by Fresenius Kabi Usa and Mylan Institutional, and is included in two NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for remifentanil hydrochloride. Two suppliers are listed for this compound.
Pharmacology for remifentanil hydrochloride
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Synonyms for remifentanil hydrochloride
1-Piperidinepropanoic acid, 4-(methoxycarbonyl)-4-((1-oxopropyl)phenylamino)-, methyl ester, monohydrochloride
132539-07-2
132875-61-7 (Parent)
3-[methoxycarbonyl-4-[(1-oxopropyl)phenylamino]1-piperidine]propanoic acid methyl ester hydrochloride
4-(Methoxycarbonyl)-4-[(1-oxopropyl)phenylamino]-1-piperidinepropanoic Acid Methyl Ester Hydrochloride
4-Carboxy-4-(N-phenylpropionamido)-1-piperidine propionic acid, dimethyl ester, monohydrochloride
5V444H5WIC
AC1L1TZ5
AC1Q3E9W
C20H28N2O5.HCl
CHEBI:32091
CHEMBL1201120
D01177
DTXSID50157614
FT-0674340
GI 87084B
GI-87084B
HE306791
LS-172838
methyl 1-(3-methoxy-3-oxopropyl)-4-(N-propanoylanilino)piperidine-4-carboxylate hydrochloride
methyl-1-(3-methoxy-3-oxopropyl)-4-[phenyl(propanoyl)amino]piperidin-4-carboxylathydrochlorid
Remifentanil HCl
Remifentanil hydrochloride (JAN/USAN)
Remifentanil hydrochloride [USAN]
Remifentanil hydrochloride solution, 100 mug/mL in methanol (as free base), certified reference material
Remifentanil hydrochloride, >=97% (HPLC), powder
Remifentanil hydrochloride, European Pharmacopoeia (EP) Reference Standard
remifentanil monohydrochloride
Remifentanyl Hydrochloride
SCHEMBL41242
Ultiva
UNII-5V444H5WIC

US Patents and Regulatory Information for remifentanil hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa REMIFENTANIL HYDROCHLORIDE remifentanil hydrochloride INJECTABLE;INJECTION 206223-003 Jan 16, 2018 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa REMIFENTANIL HYDROCHLORIDE remifentanil hydrochloride INJECTABLE;INJECTION 206223-001 Jan 16, 2018 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Institutional ULTIVA remifentanil hydrochloride INJECTABLE;INJECTION 020630-003 Jul 12, 1996 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Institutional ULTIVA remifentanil hydrochloride INJECTABLE;INJECTION 020630-002 Jul 12, 1996 AP RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for remifentanil hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Institutional ULTIVA remifentanil hydrochloride INJECTABLE;INJECTION 020630-002 Jul 12, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Institutional ULTIVA remifentanil hydrochloride INJECTABLE;INJECTION 020630-002 Jul 12, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Institutional ULTIVA remifentanil hydrochloride INJECTABLE;INJECTION 020630-003 Jul 12, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Institutional ULTIVA remifentanil hydrochloride INJECTABLE;INJECTION 020630-001 Jul 12, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Chubb
Deloitte
AstraZeneca
Farmers Insurance
Healthtrust
Mallinckrodt
Covington
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.